Jefferies Group LLC Pacira Bio Sciences, Inc. Put Options Transaction History

Jefferies Group LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Sep 21, 2023	BUY	$51.49 - $81.64 $1.12 Million - $1.77 Million	21,700 Added 129.17%	38,500 $2.24 Million
Q2 2022 Aug 15, 2022	BUY	$51.49 - $81.64 $1.12 Million - $1.77 Million	21,700 Added 129.17%	38,500 $2.25 Million
Q4 2020 Sep 21, 2023	SELL	$50.47 - $66.26 $1.1 Million - $1.44 Million	-21,700 Reduced 56.36%	16,800 $1.01 Million
Q3 2020 Nov 13, 2020	SELL	$51.97 - $63.0 $9.52 Million - $11.5 Million	-183,200 Reduced 91.6%	16,800 $1.01 Million
Q1 2020 May 15, 2020	BUY	$28.4 - $50.7 $3.69 Million - $6.59 Million	130,000 Added 185.71%	200,000 $6.71 Million
Q2 2019 Aug 14, 2019	BUY	$36.57 - $47.97 $1.46 Million - $1.92 Million	40,000 Added 133.33%	70,000 $3.04 Million
Q1 2019 May 15, 2019	SELL	$36.47 - $42.17 $1.25 Million - $1.45 Million	-34,400 Reduced 53.42%	30,000 $1.14 Million
Q4 2018 Feb 14, 2019	SELL	$41.31 - $52.16 $202,419 - $255,583	-4,900 Reduced 7.07%	64,400 $2.77 Million
Q3 2018 Nov 14, 2018	BUY	$32.85 - $52.0 $2.28 Million - $3.6 Million	69,300 New	69,300 $3.41 Million

264

50.6M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $763M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.